Patents by Inventor Isabelle Mansuy

Isabelle Mansuy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110086908
    Abstract: Provided are novel a target and drugs in the treatment of neurological disorders related to amyloid beta pathology/amyloidosis. More specifically, the use of phosphatase inhibitors for the treatment of brain impairments mediated by A?-oligomers is described.
    Type: Application
    Filed: January 22, 2008
    Publication date: April 14, 2011
    Inventors: Roger Nitsch, Marlen Knobloch, Mélissa Farinelli, Isabelle Mansuy
  • Publication number: 20100310543
    Abstract: Described are novel means in the treatment of cerebral neurological conditions such as ischemic insult of the brain. Furthermore, a kit for a non-radioactive protein serine/threonine phosphatase activity assay is provided, which is capable of detecting and distinguishing the activity of PP1, PP2A, and calcineurin (PP2B).
    Type: Application
    Filed: July 7, 2008
    Publication date: December 9, 2010
    Applicant: UNIVERSITY OF ZURICH
    Inventors: Melissa Farinelli, Isabelle Mansuy, Frabice Heitz
  • Publication number: 20100048687
    Abstract: Provided are novel a target and drugs in the treatment of neurological disorders related to amyloid beta pathology/amyloidosis. More specifically, the use of phosphatase inhibitors for the treatment of brain impairments mediated by A?-oligomers is described.
    Type: Application
    Filed: July 22, 2008
    Publication date: February 25, 2010
    Inventors: Roger Nitsch, Marlen Knobloch, Mélissa Farinelli, Isabelle Mansuy
  • Publication number: 20020170078
    Abstract: The present invention provides a transgenic nonhuman mammal and mammalian cells whose genomes encode a calcineurin inhibitor. The expression of the inhibitor is targeted to the forebrain and may be induced experimentally. The present invention further provides a composition of matter comprising the nucleic acid sequences encoding the inhibitor and additional sequences required for its targeted expression and regulation. In addition, the present invention provides methods for determining whether an agent inhibits long-term potentiation and/or learning and memory in a mammal.
    Type: Application
    Filed: March 5, 2002
    Publication date: November 14, 2002
    Inventors: Isabelle Mansuy, Eric R. Kandel